PATENT CLAIM ANALYSIS

Application Number: 15877750
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "439000"]

Abstract:
The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Claim (Index 15):
A method for providing an oral rehydration therapy, improving small intestine anatomy & increasing small intestine's villi size weight gaining, weight gaining associated with reduction in antibiotics usage, for improving weight gain whilst decreasing use of milk replacers, improving small intestine anatomy & increasing small intestine's villi size, or increasing the uptake of nutraceuticals, medicament (including oral vaccine & antibiotics) & flavour enhancers uptake, comprising step of administering a patient a composition defined in any of  claim 1 ,  2  or  3 .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.25641
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15527724', '14360863', '12685979', '14044546', '13523683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7114004507337495
- 35 USC 102 Novelty (BERT): 0.5283434288294546
- Combined Prediction Score: 0.69309474854332
- Mean Citation Score: 202.86906
- Max Citation Score: 327.8126200000001
- Similarity Product: 171.69930648766524

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test